Therapy, historical perspective

Lunenfeld, B. 2004. Historical perspectives in gonadotrophin therapy. Human Reproduction Update 10(6), 453-467. 

Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy an historical perspective and an update. EurJ Cancer 1998 34 1522-1534. 

Historical Perspective of Gene Therapy During the past several decades, the promising concept of gene therapy has emerged. This approach has... 

Many factors have contributed to the decline in cardiovascular-related mortality over the past quarter century, including lifestyle modifications, the development of multiple new drug categories, the introduction and subsequent dramatic improvements in percutaneous coronary intervention (PCI), cardiac transplantation, and advances in electrophysiology and implantable devices. One of the more important new treatments is reperfusion therapy for patients with evolving acute myocardial infarction (AMI), which has now become the standard of care for these individuals. This chapter will review selected major developments in historical perspective that led to the widespread application of pharmacological reperfusion therapy for the treatment of AMI (Fig. 2.1). 

Yernault JC. Inhalation therapy an historical perspective. Eur Respir Rev 1994 4 65-67. 

Caldwell, M. (1990). Topical wound therapy-an historical perspective. Journal of Trauma, 30, 116-122. 

Medical history data may be used in either safety or efficacy analyses. The presence of historical medical conditions may be used as covariates for inferential analyses. Also, medical histories are typically summarized to show that the therapies under study come from study populations with comparable disease histories. Medical histories may be used to determine protocol compliance and to help define a protocol-compliant study population. Medical history is considered a finding from a CDISC perspective. 

N. Krieger, et al., Hormone Replacement Therapy, Cancer, Controversies, and Women s Health Historical, Epidemiological, Biological, Clinical, and Advocacy Perspectives, Journal of Epidemiology and Community Health 59 (2005) 740-748. 

---